Status:
COMPLETED
Role of EUS in High Risk of Choledocholithiasis
Lead Sponsor:
Woo Hyun Paik
Conditions:
Choledocholithiasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to demonstrate that patients with high risk of choledocholithiasis who undergo ERCP only for patients with choledocholith in the EUS examination\[EUS-ERCP group\] have less ne...
Detailed Description
Several studies have shown that EUS testing prior to ERCP may reduce ERCP complications in patients with intermediate-risk choledocholithiasis. In other words, this results obtained by not performing ...
Eligibility Criteria
Inclusion
- Abdominal CT or US showed a common bile duct diameter \> 6mm (\>8mm in patients with previous cholecystectomy) and elevated total bilirubin from 1.8mg/dL to less than 4.0mg/dL
Exclusion
- Severe mental illness
- Severe co-morbidity (ESRD, Advanced COPD, severe Heart failure, poorly controlled blood sugar)
- Pregnancy
- Pancreatic cancer or suspected malignant tumor of the biliary tract
- Acute pancreatitis
- Patient who has confirmed biliary stones in abdominal ultrasonography or CT
- Severe cholangitis according to TG 18 guideline
- Total bilirubin \> 4mg/dL
- Patients who have difficulty with EUS or ERCP due to previous gastric surgery (Billroth II or TG with R-en-Y)
Key Trial Info
Start Date :
July 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03250286
Start Date
July 25 2017
End Date
June 5 2020
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080